UnknownPhase 1/2

Study of ORL-1M (D-mannose) in Patients With CDG-Ib

Turkey (Türkiye)5 participantsStarted 2015-03-31

Plain-language summary

Study of ORL-1M in Patients With CDG-Ib

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of CGD-1b. * Less than 18 years old. Exclusion Criteria: * Diagnosis of any other disease that is not a manifestation of CGD-1b.

What they're measuring

Improvement in hypoglycemia, diarrhea and vomiting.

Timeframe: 6 months after treatment started

Trial details

NCT IDNCT03404869

SponsorOrpha Labs

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2019-06-01

Contact for this trial

Study Coordinator Study Coordinator

+90 537 763 6241 business.development@orphalabs.com

View on ClinicalTrials.gov More CDG Ib trials